Gynecologic ExaminationPRIV-DRAPENCT07797309
Vaginal Examination Drape Supporting Women's Privacy
A study testing Privacy-supporting vaginal examination drape in people with Gynecologic Examination and Pain, run by KTO Karatay University at 1 site in Turkey (Türkiye).
Trial summary
This single-blind, parallel-group randomised controlled trial evaluates whether a vaginal examination drape designed to support women's privacy reduces pain and improves perceived privacy and examination satisfaction during gynaecological vaginal examination. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Gynecologic Examination, Pain, Patient Satisfaction
- What is being tested?
- Privacy-supporting vaginal examination drape
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 26 Aug 2026to Feb 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Aged 18 years or older
- Undergoing vaginal examination
Who cannot join
- Clinical condition requiring emergency obstetric or gynaecological intervention
- A health problem preventing cognition or communication
- Diagnosed psychological disorder (depression, post-traumatic stress disorder, bipolar disorder)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Osmaniye Training and Research Hospital, Gynaecology and Obstetrics Clinic
Osmaniye
About this study
Official title: The Effect of a Vaginal Examination Drape Designed to Support Women's Privacy on Pain, Satisfaction and Perceived Privacy: A Randomised Controlled Study
This single-blind, parallel-group randomised controlled trial evaluates whether a vaginal examination drape designed to support women's privacy reduces pain and improves perceived privacy and examination satisfaction during gynaecological vaginal examination. Women aged 18 and over undergoing vaginal examination at a gynaecology and obstetrics outpatient clinic are randomly allocated 1:1 to an intervention group, in which the privacy-supporting drape is used, or a control group receiving the clinic's routine examination practice. Immediately after the examination, pain (Visual Analogue Scale), examination satisfaction (Gynecologic Examination Satisfaction Scale) and perceived body privacy (Body Privacy in Gynaecology and Obstetrics Scale) are assessed.
Read the detailed description
Background:
Gynaecological and vaginal examinations are core services for protecting and promoting women's sexual and reproductive health and for the early detection of disease. Often described as the most intimate of examinations, the gynaecological assessment is usually performed in the lithotomy position and is frequently experienced as uncomfortable, embarrassing and highly stressful. Being fully exposed and inadequately covered is a major source of anxiety and can lead women to avoid or postpone gynaecological screening. Protecting body privacy is an indispensable part of respectful gynaecological care and is directly related to self-esteem, trust in the health professional and overall satisfaction. Unmet privacy expectations increase state anxiety, which raises muscle tension, reduces examination comfort and intensifies the perception of pain. Standard drapes and gowns leave the genital area exposed for examination while failing to fully protect the privacy of other areas.
Intervention:
A specially designed vaginal examination drape that covers the lower extremities, the pelvic region and the non-examined parts of the body, allowing only the anatomical area to be assessed to be exposed during the procedure by means of a hook-and-loop opening. The drape aims to minimise unnecessary body exposure, help the woman feel in control, encourage muscle relaxation and thereby reduce pain perception and increase examination satisfaction.
Design:
Parallel-group, single-blind, randomised controlled trial reported according to the CONSORT 2025 statement. Participants are allocated 1:1 to the intervention or control group using block randomisation (block size 4, 25 blocks) generated by an independent statistician and concealed in opaque, sealed, sequentially numbered envelopes. Because the drape is visible to participants and providers, participant and provider blinding is not possible; blinding is applied at the data-entry and analysis stages, so the trial is single blind (outcome assessor and data analyst blinded).
Hypotheses:
H1: Women examined with the privacy-supporting drape have lower pain than the control group. H2: Women examined with the drape have higher perceived privacy than the control group. H3: Women examined with the drape have higher examination satisfaction than the control group.
Sample size:
Calculated with G*Power 3.1.9.4 using an independent-samples t test comparing two group means, with an effect size of 0.60, alpha of 0.05 and power of 0.80 at a 1:1 allocation, giving a minimum of 90 women (45 per group). Increasing by 10 percent for possible data loss, 100 women (50 per group) are planned.
Statistical analysis:
Analyses are performed with SPSS 25.0. Group sociodemographic comparability is checked with the chi-square test. Between-group differences in scale scores are assessed with one-way ANOVA or the Kruskal-Wallis H test according to distribution, and mixed-design ANOVA with Bonferroni correction is used for comparisons across measurement times. Significance is set at p less than 0.05 with 95 percent confidence intervals.
Ethics:
Ethics approval will be obtained from the Non-Drug and Non-Medical Device Research Ethics Board of KTO Karatay University Faculty of Medicine, and institutional permission from the participating hospital, before the study begins. The trial is conducted in accordance with the Declaration of Helsinki, and written informed consent is obtained from all participants.
- Conditions
- Gynecologic Examination, Pain, Patient Satisfaction, Privacy
- Being tested
- Privacy-supporting vaginal examination drape
- Keywords
- Vaginal examination, Gynaecological examination, Privacy, Examination drape, Pain, Patient satisfaction, Women-centred care, Randomised controlled trial
- Medical subject headings
- Pain, Patient Satisfaction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Privacy-supporting vaginal examination drapeDevice
A specially designed drape used during vaginal examination that covers the lower extremities, pelvic region and non-examined body parts, with a hook-and-loop opening that exposes only the anatomical area being examined, applied during the examination to minimise body exposure and support privacy.
| Study group | Role | What they receive |
|---|---|---|
| Privacy-supporting drape group | Experimental | Women undergoing vaginal examination with the privacy-supporting vaginal examination drape, which covers the lower extremities, pelvis and non-examined body parts and exposes only the anatomical area being assessed via a hook-and-loop opening. Receives: Device: Privacy-supporting vaginal examination drape |
| Control group (routine practice) | No intervention | Women undergoing vaginal examination with the clinic's routine examination practice, without the privacy-supporting drape. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain during vaginal examination (Visual Analogue Scale, VAS)
Pain intensity measured on a 10 cm Visual Analogue Scale from 0 (no pain) to 10 (worst pain), completed immediately after the examination. Higher scores indicate greater pain.
Measured: Immediately after the vaginal examination (Day 1)
Perceived body privacy (Body Privacy in Gynaecology and Obstetrics Scale)
Perceived privacy measured with the Body Privacy in Gynaecology and Obstetrics Scale (Degirmen and Sayligil, 2020), a 37-item, 5-point Likert scale with general privacy, rights and privacy, ethics and privacy, and clinical privacy subscales. Higher mean scores indicate greater sensitivity to and protection of privacy.
Measured: Immediately after the vaginal examination (Day 1)
Gynaecological examination satisfaction (Gynecologic Examination Satisfaction Scale, GESS)
Satisfaction measured with the Gynecologic Examination Satisfaction Scale (Muslu, 2026), a 36-item, six-factor scale covering health personnel, examination environment, emotional reactions, menstruation-related concerns, hygiene and privacy. Higher scores indicate greater satisfaction with the gynaecological examination.
Measured: Immediately after the vaginal examination (Day 1)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Sep 2026
- Study start26 Aug 2026
- Primary completionFeb 2027 (estimated)
- Study completionFeb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gynecologic ExaminationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- KTO Karatay University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aslıhan Turan, Osmaniye Korkut Ata University
- Investigators
- Aslihan Turan, Principal investigator, KTO Karatay University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07797309
- Sponsor's protocol ID
- VAGDRAPE-2026
- Acronym
- PRIV-DRAPE
- Status last verified
- Aug 2026
- First submitted
- 26 Aug 2026
- Last updated
- 1 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of a Vaginal Examination Drape Designed to Support Women's Privacy on Pain, Satisfaction and Perceived Privacy: A Randomised Controlled Study
- ClinicalTrials.gov ID
- NCT07797309
- Acronym / sponsor ID
- PRIV-DRAPE / VAGDRAPE-2026
- Conditions
- Gynecologic Examination, Pain, Patient Satisfaction, Privacy
- Keywords
- Vaginal examination, Gynaecological examination, Privacy, Examination drape, Pain, Patient satisfaction, Women-centred care, Randomised controlled trial
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- KTO Karatay UniversityUniversity, hospital or other
- Study start
- 26 Aug 2026 (actual)
- Primary completion
- Feb 2027 (estimated)
- Study completion
- Feb 2027 (estimated)
- First posted
- 1 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This single-blind, parallel-group randomised controlled trial evaluates whether a vaginal examination drape designed to support women's privacy reduces pain and improves perceived privacy and examination satisfaction during gynaecological vaginal examination. Women aged 18 and over undergoing vaginal examination at a gynaecology and obstetrics outpatient clinic are randomly allocated 1:1 to an intervention group, in which the privacy-supporting drape is used, or a control group receiving the clinic's routine examination practice. Immediately after the examination, pain (Visual Analogue Scale), examination satisfaction (Gynecologic Examination Satisfaction Scale) and perceived body privacy (Body Privacy in Gynaecology and Obstetrics Scale) are assessed.
Detailed description
Background:
Gynaecological and vaginal examinations are core services for protecting and promoting women's sexual and reproductive health and for the early detection of disease. Often described as the most intimate of examinations, the gynaecological assessment is usually performed in the lithotomy position and is frequently experienced as uncomfortable, embarrassing and highly stressful. Being fully exposed and inadequately covered is a major source of anxiety and can lead women to avoid or postpone gynaecological screening. Protecting body privacy is an indispensable part of respectful gynaecological care and is directly related to self-esteem, trust in the health professional and overall satisfaction. Unmet privacy expectations increase state anxiety, which raises muscle tension, reduces examination comfort and intensifies the perception of pain. Standard drapes and gowns leave the genital area exposed for examination while failing to fully protect the privacy of other areas.
Intervention:
A specially designed vaginal examination drape that covers the lower extremities, the pelvic region and the non-examined parts of the body, allowing only the anatomical area to be assessed to be exposed during the procedure by means of a hook-and-loop opening. The drape aims to minimise unnecessary body exposure, help the woman feel in control, encourage muscle relaxation and thereby reduce pain perception and increase examination satisfaction.
Design:
Parallel-group, single-blind, randomised controlled trial reported according to the CONSORT 2025 statement. Participants are allocated 1:1 to the intervention or control group using block randomisation (block size 4, 25 blocks) generated by an independent statistician and concealed in opaque, sealed, sequentially numbered envelopes. Because the drape is visible to participants and providers, participant and provider blinding is not possible; blinding is applied at the data-entry and analysis stages, so the trial is single blind (outcome assessor and data analyst blinded).
Hypotheses:
H1: Women examined with the privacy-supporting drape have lower pain than the control group. H2: Women examined with the drape have higher perceived privacy than the control group. H3: Women examined with the drape have higher examination satisfaction than the control group.
Sample size:
Calculated with G*Power 3.1.9.4 using an independent-samples t test comparing two group means, with an effect size of 0.60, alpha of 0.05 and power of 0.80 at a 1:1 allocation, giving a minimum of 90 women (45 per group). Increasing by 10 percent for possible data loss, 100 women (50 per group) are planned.
Statistical analysis:
Analyses are performed with SPSS 25.0. Group sociodemographic comparability is checked with the chi-square test. Between-group differences in scale scores are assessed with one-way ANOVA or the Kruskal-Wallis H test according to distribution, and mixed-design ANOVA with Bonferroni correction is used for comparisons across measurement times. Significance is set at p less than 0.05 with 95 percent confidence intervals.
Ethics:
Ethics approval will be obtained from the Non-Drug and Non-Medical Device Research Ethics Board of KTO Karatay University Faculty of Medicine, and institutional permission from the participating hospital, before the study begins. The trial is conducted in accordance with the Declaration of Helsinki, and written informed consent is obtained from all participants.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Privacy-supporting drape group | Experimental | Device: Privacy-supporting vaginal examination drapeWomen undergoing vaginal examination with the privacy-supporting vaginal examination drape, which covers the lower extremities, pelvis and non-examined body parts and exposes only the anatomical area being assessed via a hook-and-loop opening. |
| Control group (routine practice) | No intervention | –Women undergoing vaginal examination with the clinic's routine examination practice, without the privacy-supporting drape. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Aged 18 years or older
- Undergoing vaginal examination
Key exclusion criteria (3 listed)
- Clinical condition requiring emergency obstetric or gynaecological intervention
- A health problem preventing cognition or communication
- Diagnosed psychological disorder (depression, post-traumatic stress disorder, bipolar disorder)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Privacy-supporting vaginal examination drapeA specially designed drape used during vaginal examination that covers the lower extremities, pelvic region and non-examined body parts, with a hook-and-loop opening that exposes only the anatomical area being examined, applied during the examination to minimise body exposure and support privacy. | Device | Privacy-supporting drape group |
Primary outcome
Pain during vaginal examination (Visual Analogue Scale, VAS)
Time frame: Immediately after the vaginal examination (Day 1)
Pain intensity measured on a 10 cm Visual Analogue Scale from 0 (no pain) to 10 (worst pain), completed immediately after the examination. Higher scores indicate greater pain.
Perceived body privacy (Body Privacy in Gynaecology and Obstetrics Scale)
Time frame: Immediately after the vaginal examination (Day 1)
Perceived privacy measured with the Body Privacy in Gynaecology and Obstetrics Scale (Degirmen and Sayligil, 2020), a 37-item, 5-point Likert scale with general privacy, rights and privacy, ethics and privacy, and clinical privacy subscales. Higher mean scores indicate greater sensitivity to and protection of privacy.
Gynaecological examination satisfaction (Gynecologic Examination Satisfaction Scale, GESS)
Time frame: Immediately after the vaginal examination (Day 1)
Satisfaction measured with the Gynecologic Examination Satisfaction Scale (Muslu, 2026), a 36-item, six-factor scale covering health personnel, examination environment, emotional reactions, menstruation-related concerns, hygiene and privacy. Higher scores indicate greater satisfaction with the gynaecological examination.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Gynecologic Examination
RecruitingObservational study
Assessment of Sexual Well-being in Patients With Gynecologic Cancer and Their Partners: the ONCOSEX Study
Sexual Wellness, Gynecologic Cancers
Active, not recruiting
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Ovary Cancer, Endometrial Cancer
Recruiting
Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
Gynecologic Cancer, Remission
RecruitingPhase 2
Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy
Urothelial Carcinoma Bladder
Not yet recruiting
Effects of a Self-Regulation Based E-MOTE Program Delivered Via an AI-Assisted Robot and Supported by Mobile Platforms for Newly Diagnosed Gynecologic Cancer Patients
Nursing, Gynecological Cancers
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Aslihan Turan principal investigator
KTO Karatay University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Privacy-supporting vaginal examination drape in people with Gynecologic Examination and Pain, run by KTO Karatay University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 1 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain during vaginal examination (Visual Analogue Scale, VAS) (time frame: Immediately after the vaginal examination (Day 1)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2026.